Abstract
Candida species are the major cause of mortality in both immunocompromised and critically ill patients. Therefore, the early diagnosis and differentiation of Candida species isolated from clinical samples is principally important due to their inherently variable antifungal resistance pattern. Herein, rapid and species-specific polymerase chain reaction (PCR)-based molecular method was developed for the identification of the four species of Candida most commonly isolated from clinical specimens, namely Candida albicans, Candida parapsilosis, Candida glabrata and Candida tropicalis. The developed method targeted the phospholipase B gene (PLB) as a novel target. We determined the sequences of this gene in previous work. The primers designed achieved highly specific identification of the selected species using simplex PCR assay, which were confirmed by sequencing. There was no cross-amplification of other Candida species nor other fungal organisms tested. The simplex PCR assay yielded detection limits of 1 to 10 cells/ml and 10 fg/µl DNA. These results showed that the PLB gene provides a novel target that could be used for the identification and detection of medically important Candida species from the clinical samples.
Highlights
Invasive infections by Candida species are the most common cause of mortality in patients undergoing invasive procedures and immunocompromised patients (Ascioglu et al, 2002; Leroy et al, 2009)
Rapid and species-specific polymerase chain reaction (PCR)-based molecular method was developed for the identification of the four species of Candida most commonly isolated from clinical specimens, namely Candida albicans, Candida parapsilosis, Candida glabrata and Candida tropicalis
The ITS1 and ITS4 PCR amplification results of other American type culture collection (ATCC) strains of Candida species such as Candida famata, Candida guilliermondii, Candida lusitaniae, Candida metapsilosis and Candida orthopsilosis are shown in Figure 1B with product sizes of approximately 625, 610, 370, 517 and 513 bp, respectively
Summary
Invasive infections by Candida species are the most common cause of mortality in patients undergoing invasive procedures and immunocompromised patients (Ascioglu et al, 2002; Leroy et al, 2009). The early diagnosis and differentiation of Candida species isolated from clinical samples is principally important due. Res. Species Candida albicans Candida dubliniensis Candida famata Candida glabrata Candida guilliermondii Candida kefyr Candida krusei Candida lusitaniae Candida metapsilosis Candida parapsilosis Candida rugosa Candida orthopsilosis Candida tropicalis Aspergillus flavus Aspergillus fumigatus Aspergillus niger Aspergillus terreus Cryptococcus neoformans Cryptococcus humicolus
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
